Please assess the completion status of the following clinical trial:

Trial Title: A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient with a liver transplant performed in the previous year and for whom the conversion from Prograf® to Advagraf® was decided by the physician.~Exclusion Criteria:~* Patient participating in an interventional clinical trial at the time of enrolment into the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1:early conversion from Prograf® to Advagraf® (Type: None): patients converted from Prograf® to Advagraf® in the first 3 months after transplantation
- 2:late conversion from Prograf® to Advagraf® (Type: None): patients converted from Prograf® to Advagraf® between 3 months and one year after transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).